Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 9 of 9 descriptions
No. | 薬物名(臨床試験情報から抽出) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Risankizumab | 1件: Risankizumab Risankizumab (risankizumab-rzaa) | 1件: Risankizumab
Risankizumab
(Risankizumab, Risankizumab, Risankizumab-rzaa) 💬1. Risankizumab
| 1件: IL23A IL23A 💬1. Risankizumab
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 4件: 37 37, 96, 97, 271 💬
| ||||||||||||||
2 | Risankizumab (Genetical Recombination) | 1件: Risankizumab Risankizumab (risankizumab-rzaa) | 1件: Risankizumab
Risankizumab
(Risankizumab, Risankizumab, Risankizumab-rzaa) 💬2. Risankizumab (Genetical Recombination)
| 1件: IL23A IL23A 💬2. Risankizumab (Genetical Recombination)
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 1件: 97 97 💬2. Risankizumab (Genetical Recombination)
| ||||||||||||||
3 | Risankizumab 10 mg/ml | 1件: Risankizumab Risankizumab (risankizumab-rzaa) | 1件: Risankizumab
Risankizumab
(Risankizumab, Risankizumab, Risankizumab-rzaa) 💬3. Risankizumab 10 mg/ml
| 1件: IL23A IL23A 💬3. Risankizumab 10 mg/ml
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 1件: 96 96 💬3. Risankizumab 10 mg/ml
| ||||||||||||||
4 | Risankizumab 180 mg SC | 1件: Risankizumab Risankizumab (risankizumab-rzaa) | 1件: Risankizumab
Risankizumab
(Risankizumab, Risankizumab, Risankizumab-rzaa) 💬4. Risankizumab 180 mg SC
| 1件: IL23A IL23A 💬4. Risankizumab 180 mg SC
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 1件: 96 96 💬4. Risankizumab 180 mg SC
| ||||||||||||||
5 | Risankizumab 600 mg IV | 1件: Risankizumab Risankizumab (risankizumab-rzaa) | 1件: Risankizumab
Risankizumab
(Risankizumab, Risankizumab, Risankizumab-rzaa) 💬5. Risankizumab 600 mg IV
| 1件: IL23A IL23A 💬5. Risankizumab 600 mg IV
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 1件: 96 96 💬5. Risankizumab 600 mg IV
| ||||||||||||||
6 | Risankizumab 90 mg/ml | 1件: Risankizumab Risankizumab (risankizumab-rzaa) | 1件: Risankizumab
Risankizumab
(Risankizumab, Risankizumab, Risankizumab-rzaa) 💬6. Risankizumab 90 mg/ml
| 1件: IL23A IL23A 💬6. Risankizumab 90 mg/ml
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 1件: 96 96 💬6. Risankizumab 90 mg/ml
| ||||||||||||||
7 | Risankizumab IV | 1件: Risankizumab Risankizumab (risankizumab-rzaa) | 1件: Risankizumab
Risankizumab
(Risankizumab, Risankizumab, Risankizumab-rzaa) 💬7. Risankizumab IV
| 1件: IL23A IL23A 💬7. Risankizumab IV
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 2件: 96 96, 97 💬
| ||||||||||||||
8 | Risankizumab On-Body Injector (OBI) | 1件: Risankizumab Risankizumab (risankizumab-rzaa) | 1件: Risankizumab
Risankizumab
(Risankizumab, Risankizumab, Risankizumab-rzaa) 💬8. Risankizumab On-Body Injector (OBI)
| 1件: IL23A IL23A 💬8. Risankizumab On-Body Injector (OBI)
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 1件: 96 96 💬8. Risankizumab On-Body Injector (OBI)
| ||||||||||||||
9 | Risankizumab SC | 1件: Risankizumab Risankizumab (risankizumab-rzaa) | 1件: Risankizumab
Risankizumab
(Risankizumab, Risankizumab, Risankizumab-rzaa) 💬9. Risankizumab SC
| 1件: IL23A IL23A 💬9. Risankizumab SC
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 2件: 96 96, 97 💬
|